Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gogas

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 20, 2012
Clinical experience of using Oncotype DX as an additional treatment decision tool in early breast cancer - a retrospective analysis from 5 Greek institutionsC Markopoulos, Gr Xepapadakis, V Venizelos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2009
Utility of adjuvant systemic therapy in melanomaA M M Eggermont, A Testori, J Marsden, et al.
Oncology|November 6, 2002
Docetaxel in combination with dacarbazine in patients with advanced melanomaD Bafaloukos, G Aravantinos, G Fountzilas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerG Aravantinos, D Bafaloukos, G Fountzilas, et al.
Journal of Chemotherapy (Florence, Italy)|March 5, 2004
Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II studyA Polyzos, N Tsavaris, C Kosmas, et al.
British Journal of Cancer|October 21, 2004
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, C Papadimitriou, H Linardou, et al.
British Journal of Cancer|June 4, 2009
Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer casesS Armaou, M Pertesi, F Fostira, et al.
Journal of Chemotherapy (Florence, Italy)|December 13, 2007
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, C Markopoulos, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology GroupH Gogas, A Polyzos, I Stavrinidis, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 20, 2012
Clinical experience of using Oncotype DX as an additional treatment decision tool in early breast cancer - a retrospective analysis from 5 Greek institutionsC Markopoulos, Gr Xepapadakis, V Venizelos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2009
Utility of adjuvant systemic therapy in melanomaA M M Eggermont, A Testori, J Marsden, et al.
Oncology|November 6, 2002
Docetaxel in combination with dacarbazine in patients with advanced melanomaD Bafaloukos, G Aravantinos, G Fountzilas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerG Aravantinos, D Bafaloukos, G Fountzilas, et al.
Journal of Chemotherapy (Florence, Italy)|March 5, 2004
Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II studyA Polyzos, N Tsavaris, C Kosmas, et al.
British Journal of Cancer|October 21, 2004
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, C Papadimitriou, H Linardou, et al.
British Journal of Cancer|June 4, 2009
Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer casesS Armaou, M Pertesi, F Fostira, et al.
Journal of Chemotherapy (Florence, Italy)|December 13, 2007
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, C Markopoulos, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology GroupH Gogas, A Polyzos, I Stavrinidis, et al.
Pageof 8